SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The conclave brought together over 1,000 delegates from across India and internationally
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
PMDA is regarded among the most stringent regulatory bodies globally
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Subscribe To Our Newsletter & Stay Updated
